NCT05580003 A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy People Status COMPLETED Phase PHASE1
NCT05579977 Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity Status TERMINATED Phase PHASE2
NCT05579847 Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy Status COMPLETED Phase N/A
NCT05577819 Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF Status RECRUITING Phase NA
NCT05576051 To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting. Status COMPLETED Phase N/A
NCT05574010 A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it) Status TERMINATED Phase PHASE1/PHASE2
NCT05573555 TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05572567 Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT05572450 Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain Status COMPLETED Phase NA
NCT05569928 In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects Status UNKNOWN Phase NA
NCT05568719 Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively Status RECRUITING Phase PHASE3
NCT05568407 A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer Status TERMINATED Phase N/A
NCT05567952 A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir Status COMPLETED Phase PHASE2
NCT05567887 A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT05565391 A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma Status COMPLETED Phase N/A
NCT05560555 Retrospective Study Collecting Neurological Follow-up of Hereditary Transthyretin Amyloidosis (ATTRv) Patients Included in B3461028 and B3461045. Status COMPLETED Phase N/A